1. A Phase 2a Study to Evaluate the Safety of MEDI8852 in Outpatient Adults with Acute, Uncomplicated Influenza A. (4th October 2017) Authors: Ali, Omar; Takas, Therese; Nyborg, Andrew C; Jensen, Kathryn M; Dubovsky, Filip; Mallory, Raburn Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Single Dose Monoclonal Antibody (mAb) Immunoprophylaxis Strategy to Prevent RSV Disease in All Infants: Results of the First in Infant Study with MEDI8897. (4th October 2017) Authors: Domachowske, Joseph B; Khan, Anis; Esser, Mark T; Jensen, Kathryn M; Takas, Therese; Villafana, Tonya; Dubovsky, Filip; Griffin, M Pamela Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial. Issue 12 (December 2015) Authors: O'Brien, Katherine L; Chandran, Aruna; Weatherholtz, Robert; Jafri, Hasan S; Griffin, M Pamela; Bellamy, Terramika; Millar, Eugene V; Jensen, Kathryn M; Harris, Brian S; Reid, Raymond; Moulton, Lawrence H; Losonsky, Genevieve A; Karron, Ruth A; Santosham, Mathuram Journal: Lancet infectious diseases Issue: Volume 15:Issue 12(2015:Dec.) Page Start: 1398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗